Views of Wall Street’s Leading Experts on Arcadia Biosciences Inc

Rosalind Gate

With 6.17 million shares changed hands, the volume of the stock remained heavier than its average volume of 8010.0 shares. During the session, the Packaged Foods company that operates in wider Consumer Defensive sector, reached to the highest price of $6.71 whereas the lowest price it dropped to was $3.43. The 52-week range on RKDA shows that it touched its highest point at $10.31 and its lowest point at $2.53 during that stretch. It currently has a 1-year price target of $12.00. Beta for the stock currently stands at 0.56.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RKDA was up-trending over the past week, with a rise of 27.95%, but this was up by 39.42% over a month. Three-month performance dropped to -7.88% while six-month performance rose 62.46%. The stock lost -25.00% in the past year, while it has gained 59.14% so far this year. A look at the trailing 12-month EPS for RKDA yields -5.52 with Next year EPS estimates of -2.42. For the next quarter, that number is -0.54. This implies an EPS growth rate of 19.24% for this year and 5.47% for next year.

Float and Shares Shorts:

At present, 1.37 million RKDA shares are outstanding with a float of 1.36 million shares on hand for trading. On 2025-09-15, short shares totaled 15233.0, which was 111.00000000000001 higher than short shares on 1755216000.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, RKDA reported revenue of $1455000.0 and operating income of -$5990000.0. The EBITDA in the recently reported quarter was -$6427000.0 and diluted EPS was -$3.26.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for RKDA since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With RKDA analysts setting a high price target of 12.0 and a low target of 12.0, the average target price over the next 12 months is 12.0. Based on these targets, RKDA could surge 170.27% to reach the target high and rise by 170.27% to reach the target low. Reaching the average price target will result in a growth of 170.27% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.1 being high and -$1.1 being low. For RKDA, this leads to a yearly average estimate of -$1.1. The surprise factor in the prior quarter was -$0.98. Based on analyst estimates, the high estimate for the next quarter is -$0.66 and the low estimate is -$0.66. The average estimate for the next quarter is thus -$0.66.

Sete News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.